Register
Login

Trending Topic

abstract blue eye
8 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

On 28 May 2024, enrolment in phase III clinical trials for sozinibercept in neovascular age-related macular degeneration (nAMD) was completed.1 These trials include two large multicentre, double-masked, randomized controlled trials (RCTs): COAST (OPT-302 with aflibercept in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757636) and ShORe (OPT-302 with ranibizumab in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757610).2,3 These trials represent one of the largest phase […]

Emilio de Almeida Torres Netto, WOC 2018 – ICO-Allergan Advanced Research Fellowship Award 2018

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Jun 26th 2018

We caught up with Dr Emilio de Almeida Torres Netto, of the University of Zurich, Switzerland, at the WOC annual meeting 2018. Dr de Almeida Torres Netto was recently awarded the ICO-Allergan Advanced Research Fellowship Award for his work in corneal biomechanics, keratoconus, and cross-linking, which he discusses in this video.

Questions:

1. You were recently granted the ICO-Allergan Advanced Research Fellowship Award, could you tell us a bit about your research for this award? (0:19)

Filmed at the 2018 World Ophthalmology Congress (WOC) of the International Council of Ophthalmology (ICOPH), June 2018, Barcelona, Spain.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup